Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Med-tech firm CoAxia’s assets were sold Monday, but CEO Andrew Weiss already is off leading his next venture, a California startup aiming to treat high blood pressure.
CoAxia, which was developing technology to treat ischemic stroke, closed the doors to its Twin Cities office in recent months. The company at one point employed about 45 people. Weiss is now serving as CEO of ReCor Medical, a venture-backed startup that treats high blood pressure using ultrasound.
Help employers find you! Check out all the jobs and post your resume.
